Risdiplam Patent Expiration
Risdiplam is Used for treating spinal muscular atrophy. It was first introduced by Genentech Inc
Risdiplam Patents
Given below is the list of patents protecting Risdiplam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Evrysdi | US12122789 | Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making | Apr 15, 2041 | Genentech Inc |
| Evrysdi | US11534444 | Treatment of SMA | Oct 04, 2038 | Genentech Inc |
| Evrysdi | US11938136 | Compositions for treating spinal muscular atrophy | Nov 08, 2036 | Genentech Inc |
| Evrysdi | US11827646 | Compounds for treating spinal muscular atrophy | Jan 25, 2036 | Genentech Inc |
| Evrysdi | US9969754 | Compounds for treating spinal muscular atrophy | May 11, 2035 | Genentech Inc |
| Evrysdi | US9586955 | Compounds for treating spinal muscular atrophy | Feb 08, 2033 | Genentech Inc |
Risdiplam's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List